bxp inc. - BXP
BXP
Close Chg Chg %
64.20 2.42 3.77%
Closed Market
66.62
+2.42 (3.77%)
Volume: 1.22M
Last Updated:
May 12, 2025, 3:59 PM EDT
Company Overview: bxp inc. - BXP
BXP Key Data
Open $66.15 | Day Range 65.96 - 67.15 |
52 Week Range 54.22 - 90.11 | Market Cap $10.17B |
Shares Outstanding 158.33M | Public Float 157.96M |
Beta 1.15 | Rev. Per Employee N/A |
P/E Ratio N/A | EPS -$0.03 |
Yield 610.50% | Dividend $0.98 |
EX-DIVIDEND DATE Mar 31, 2025 | SHORT INTEREST N/A |
AVERAGE VOLUME 1.48M |
BXP Performance
1 Week | 3.72% | ||
1 Month | 9.83% | ||
3 Months | -6.04% | ||
1 Year | 8.29% | ||
5 Years | -11.14% |
BXP Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
21
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 74.471 | |
Number of Ratings | 21 | Current Quarters Estimate | 0.412 | |
FY Report Date | 06 / 2025 | Current Year's Estimate | 1.794 | |
Last Quarter’s Earnings | 0.39 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 0.09 | Next Fiscal Year Estimate | 1.897 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 8 | 8 | 8 | 8 |
Mean Estimate | 0.41 | 0.48 | 1.79 | 1.90 |
High Estimates | 0.63 | 0.68 | 2.58 | 2.86 |
Low Estimate | 0.23 | 0.32 | 1.31 | 1.25 |
Coefficient of Variance | 30.10 | 25.05 | 24.59 | 27.17 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 7 | 8 | 7 |
OVERWEIGHT | 1 | 1 | 1 |
HOLD | 11 | 12 | 12 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 2 | 2 | 2 |
MEAN | Overweight | Overweight | Hold |
SEC Filings for Bxp Inc. - BXP
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Bxp Inc. - BXP
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Apr 2, 2025 | William H Walton Director | 7,789 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2025 | Bruce W. Duncan Director | 10,520 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2025 | Matthew J. Lustig Director | 18,001 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2025 | Carol B. Einiger Director | 32,435 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2025 | Mary E. Kipp Director | 5,912 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2025 | Joel Irwin Klein Director | 20,282 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2025 | Derek Anthony West Director | 2,752 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 7, 2025 | Donna D. Garesche EVP, Chief HR Officer | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $67.87 per share | 0.00 |
Oct 2, 2024 | Tony West Director | 2,023 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Sep 11, 2024 | Raymond A. Ritchey Senior EVP | 21,835 | Conversion of derivative security | 0.00 |
Sep 11, 2024 | Raymond A. Ritchey Senior EVP | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74.25 per share | 0.00 |